Innovation

Blog Post

Quest Podcast: More CMT Clinical Trials Than Ever Before: Inside the Research Turning Point

By MDA Staff | September 20, 2026
Blog Post

FDA Approves First Muscle-Targeted Therapy for SMA: A Conversation with Dr. Se-Jin Lee

By MDA Staff | September 11, 2026
Researcher Asuka Eguchi in a white lab coat smiles while holding a pipette at a laboratory workstation.
Featured Article

From Research to Reality: Meet 2 Researchers Driving Drug Development Progress

By Janet Celosia | August 21, 2026
Orange and blue spheres connected by intersecting white threads form an abstract network on an orange background.
Featured Article

How Proteomics Could Solve Puzzling Neuromuscular Diagnoses

By Chris Anselmo | August 20, 2026
A young woman stands at a podium on stage at a conference
Blog Post

Access, Impact, and Connection at the MDA Clinical & Scientific Conference

By Rebecca Hume | July 30, 2026
Detailed 3D illustration of a human heart with visible arteries and veins against a dark background.
Featured Article

New Cardiac Insights Show How Neuromuscular Diseases Affect the Heart

By Chris Anselmo | May 26, 2026
Pharmaceutical research and medical concepts
Blog Post

Beyond Approval: Why Drug Development Doesn’t End at FDA Sign-Off

By Megan Kramer-Salvitti | April 20, 2026
John Crowly stands at a podium in the spotlight in a dark auditorium. Signage on the podium and behind him says MDA Clinical and Scientific Conference.
Blog Post

Pompe Disease and the Real Story Behind Dr. Stonehill, John Crowley, and ‘Extraordinary Measures’

By Amy Bernstein (Updated) | April 13, 2026
Adrian Krainer, PhD
Blog Post

Letter from the Editor: How New Higher-Dose Regimen for Spinraza Brings More Hope

By Mindy Henderson | March 30, 2026
wooden blocks spell out the word content with word bubbles above that say news and stories and photos and blog
Blog Post

In Case You Missed It…

By Rebecca Hume | March 8, 2026